U.S. flag

An official website of the United States government

NM_016335.6(PRODH):c.1576C>T (p.Gln526Ter) AND Proline dehydrogenase deficiency

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Mar 14, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001861053.7

Allele description [Variation Report for NM_016335.6(PRODH):c.1576C>T (p.Gln526Ter)]

NM_016335.6(PRODH):c.1576C>T (p.Gln526Ter)

Gene:
PRODH:proline dehydrogenase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q11.21
Genomic location:
Preferred name:
NM_016335.6(PRODH):c.1576C>T (p.Gln526Ter)
HGVS:
  • NC_000022.11:g.18913477G>A
  • NG_008226.3:g.28077C>T
  • NG_009052.1:g.12255G>A
  • NM_001195226.2:c.1252C>T
  • NM_016335.6:c.1576C>TMANE SELECT
  • NP_001182155.2:p.Gln418Ter
  • NP_057419.5:p.Gln526Ter
  • NC_000022.10:g.18900990G>A
  • NG_008226.2:g.28077C>T
  • NM_016335.4:c.1576C>T
  • NM_016335.5:c.1576C>T
Protein change:
Q418*
Links:
dbSNP: rs372187772
NCBI 1000 Genomes Browser:
rs372187772
Molecular consequence:
  • NM_001195226.2:c.1252C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_016335.6:c.1576C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Proline dehydrogenase deficiency (HYRPRO1)
Synonyms:
PROLINE OXIDASE DEFICIENCY; Hyperprolinemia type 1
Identifiers:
MONDO: MONDO:0009400; MedGen: C0268529; Orphanet: 419; OMIM: 239500

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002210006Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 14, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003812368Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Apr 24, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002210006.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

ClinVar contains an entry for this variant (Variation ID: 1303133). This variant has not been reported in the literature in individuals affected with PRODH-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gln526*) in the PRODH gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 75 amino acid(s) of the PRODH protein. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV003812368.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024